Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/C3HirPfoLXc/256051.php
Friday, 8 February 2013
Aripiprazole (ABILIFY�) Approved For The Treatment Of Moderate To Severe Manic Episodes In Bipolar I Disorder In Adolescents
Otsuka Pharmaceutical Co., Ltd. announced today that the European Medicines Agency (EMA) has approved a label extension for aripiprazole for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 and older. This will be the first centrally approved indication for the treatment of moderate to severe manic episodes in Bipolar I Disorder in this age group in Europe...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment